Loading…
Vyzkumny Ustav Organickych Syntez, a.s.
Tradition since 1941
About
VUOS (Research Institute of Organic Syntheses) is a Czech contract research, testing and production company in Rybitví near Pardubice, active in production, research and development in organic chemistry and in toxicology testing of pesticides, biocides and medical devices. It states it covers the chain from literature search, process development and laboratory synthesis through scale-up and pilot-plant verification to production "from grams up to metric tons", alongside analytical and toxicological testing. It states that more than 20% of its employees work in R&D.
Deterministic scores · rules-based, not AIiHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Research excellence iBlends publication volume (tiers from 4 points for any output up to 34 at 50,000+ papers), patent count (3 to 22 points at 1,500+), citation impact (2 to 20 points at 80+), and how many of the 14 research capabilities the profile checks - 1.8 points each, capped at 24. Levels: 80+ World-leading | 60-79 Research-intensive | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
4Emerging
Discovery capability iAdds points for six discovery checkboxes: drug discovery, target discovery, and AI drug discovery are 14 each; biomarker development, translational medicine, and gene editing are 12 each. Each research technology listed adds 2 more points, capped at 22. Levels: 80+ Pioneering | 60-79 Advanced | 40-59 Developing | below 40 Foundational. Whether this dimension matters for you depends on your specific project.
0Foundational
Translational readiness iScores four checkboxes - translational medicine (24), clinical research (22), technology transfer (18), core facilities offered (14) - plus 4 points per facility listed on the profile, capped at 22. Levels: 80+ Clinic-ready | 60-79 Translational | 40-59 Bridging | below 40 Bench-focused. Whether this dimension matters for you depends on your specific project.
14Bench-focused
Commercialization iCombines patent count (3 to 24 points at 1,000+), spin-out companies (3 to 22 points at 100+), industry partnerships (2 to 18 points at 200+), 14 points for a technology-transfer office, and 5 points per licensable technology listed, capped at 22. Levels: 80+ Highly translatable | 60-79 Strong pipeline | 40-59 Active | below 40 Early-stage. Whether this dimension matters for you depends on your specific project.
0Early-stage
Funding scale iUses active grant count (tiers from 4 points up to 32 at 2,000+ grants), total grant funding (6 points for any up to 40 at 1.5 billion USD or more), and funding-source diversity at 4 points per source listed, capped at 22. Levels: 80+ Exceptionally funded | 60-79 Well-funded | 40-59 Funded | below 40 Limited. Whether this dimension matters for you depends on your specific project.
0Limited
Infrastructure iMeasures scale: principal investigators (5 to 30 points at 1,500+), core-facility types listed (3.2 points each, capped at 26), facilities on the profile (4 points each, capped at 22), and employee count (3 to 22 points at 20,000+). Levels: 80+ Comprehensive | 60-79 Extensive | 40-59 Solid | below 40 Focused. Whether this dimension matters for you depends on your specific project.
0Focused
Research & discovery capabilities
Sponsored researchCore facilities offered
Research areas
Organic synthesisToxicology
Live record · illustrative seed data · scores deterministic, rules-based — not AI.